Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's revision tag has been updated to v3.6.3, replacing v3.6.2, indicating a small update to the page's versioning rather than substantive content changes.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision: v3.6.2 has been added as the page’s build/version indicator. The underlying study details and page structure remain unchanged.SummaryDifference0.1%

- Check30 days agoChange DetectedRecruitment status was updated to indicate no longer looking for participants, informing users that enrollment is closed. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and makes a formatting change to the Intervention/Treatment heading, along with a revision update to v3.6.0.SummaryDifference0.5%

- Check37 days agoChange DetectedThe page shows a new Revision: v3.5.5, replacing the previous v3.5.4, indicating an updated page revision.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This is a minor administrative update to the page's versioning information and does not affect the study details or how the page functions.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page revision was updated to v3.5.3, indicating a newer version of the page. This likely reflects internal updates or fixes and does not imply changes to the displayed study information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.